KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Equity (2016 - 2025)

Medpace Holdings' Return on Equity history spans 10 years, with the latest figure at 1.2% for Q4 2025.

  • For Q4 2025, Return on Equity rose 72.0% year-over-year to 1.2%; the TTM value through Dec 2025 reached 1.2%, up 72.0%, while the annual FY2025 figure was 0.7%, 12.0% up from the prior year.
  • Return on Equity reached 1.2% in Q4 2025 per MEDP's latest filing, down from 1.86% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.86% in Q3 2025 to a low of 0.19% in Q1 2021.
  • Average Return on Equity over 5 years is 0.61%, with a median of 0.53% recorded in 2023.
  • Peak YoY movement for Return on Equity: decreased -25bps in 2024, then skyrocketed 141bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.2% in 2021, then skyrocketed by 239bps to 0.67% in 2022, then dropped by -18bps to 0.55% in 2023, then decreased by -14bps to 0.47% in 2024, then skyrocketed by 153bps to 1.2% in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Return on Equity are 1.2% (Q4 2025), 1.86% (Q3 2025), and 1.09% (Q2 2025).